HOME >> MEDICINE >> NEWS
Cholesterol-lowering drugs should revolutionise treatment of heart attack and stroke

Results of a landmark study published in the July 6 issue of THE LANCET highlight how the prescribing of statins to lower blood cholesterol could reduce rates of heart attack and stroke by at least a third.

Vascular disease is the leading cause of death in many countries. Statins are usually only given to people who have heart disease and raised blood cholesterol. New findings from the Heart Protection Study (HPS) led by Rory Collins from the University of Oxford's Clinical Trial Service Unit show that statins also reduce the risk of heart attack and stroke in people who have diabetes, arterial disease, or in individuals who have previously had a stroke. Most strikingly, the study found substantial benefits even among those high-risk patients considered to have "normal" or "low" blood cholesterol concentrations. The HPS study provides definite evidence that guidelines should be changed so that a statin is considered for anybody at an increased risk of heart attack or stroke-regardless of their blood cholesterol concentration.

Over 20,000 UK adults (aged 40-80) with coronary disease, other occlusive arterial disease, or diabetes were randomly allocated to receive daily doses of 40 mg simvastatin or placebo for five years. Death from all causes was reduced from 14.7% (for patients given placebo) to 12.9% (for patients given simvastatin), mainly due to an 18% relative reduction in the coronary death rate in patients assigned simvastatin.

There were also relative reductions of around 25% for non-fatal heart attack or coronary death, for non-fatal or fatal stroke, and for coronary or non-coronary revascularisation. Simvastatin was well tolerated with no major side-effects, and its benefits were additional to those of other cardioprotective treatments such as aspirin, - -blockers, and ACE inhibitors.

HPS also assessed the effects of using antioxidant vitamin supplements (600mg vitamin E, 250mg vitamin C and 20mg beta-carotene daily) in people
'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-20-7424-4949
Lancet
4-Jul-2002


Page: 1 2 3

Related medicine news :

1. Cholesterol-lowering drug may also reduce risk of blood clots
2. Cholesterol-lowering drug may slow Alzheimers progression
3. Cholesterol-lowering medications may reduce risk of glaucoma
4. Cholesterol-lowering drugs may help stroke patients get well
5. Cholesterol-lowering drugs safe and effective in children
6. Cholesterol-lowering drugs provide double protection against heart disease
7. UW research shows risk factors for relapse among health care professionals who abuse drugs
8. New studies show mixed results on epilepsy drugs and birth defects
9. Newly discovered pathway might help in design of cancer drugs
10. Study examines consequences of Thailands war on drugs
11. Computational tool predicts how drugs work in cells, advancing efforts to design better medicines

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – today announced the 10th Anniversary of Blood Cancer Awareness Month (BCAM) ...
(Date:8/31/2020)... , ... August 31, 2020 , ... ... innovative higher-learning opportunities through high-quality, career-relevant, and affordable online education – is proud ... . , Among the first of its kind in the nation, the ...
(Date:8/31/2020)... ... August 31, 2020 , ... Dr. ... with persons with autism and other developmental disabilities, as well as supporting staff ... education, adolescents with autism, school consultation, and staff development. She joined the company ...
(Date:8/28/2020)... (PRWEB) , ... August 28, 2020 , ... ... a one-year subscription to a customized Lighthouse Health & Wellness mobile app and ... of this project. Motorola Solutions Foundation awards grants each year to organizations, such ...
(Date:8/27/2020)... ... August 27, 2020 , ... Walk-in Dermatology’s SK-IN Medical Aesthetics ... Greenvale, New York location. , Loren received her New York esthetic license ... in chemical peels, microdermabrasion, Hydrafacial MD, dermaplaning, facial lymphatic, and various laser procedures. ...
Breaking Medicine News(10 mins):
(Date:8/31/2020)... ... 31, 2020 , ... Welltech1, the first Israeli VC fund ... $400,000 in PopBase, one of two start-ups that beat 152 companies in the ... , The competition was part of the GWI’s The Wellness Moonshot: A ...
(Date:8/28/2020)... ... August 28, 2020 , ... Cano Health, LLC, a ... Florida and San Antonio is happy to announce that it has selected Tejano ... this capacity he will serve as community advisor, advertising talent, and creative consultant ...
(Date:8/27/2020)... ... August 27, 2020 , ... Austin Oral Surgery – an oral and maxillofacial ... David Szalay, DDS, MD, has joined the practice. An accomplished oral and maxillofacial surgeon, ... which is scheduled to open this fall. The new office is slated for 1601 ...
Breaking Medicine Technology:
Cached News: